Analyses of measuring tools comparing the quality of life in patients with multiple sclerosis

Abstract

Multiple sclerosis (MS) is an autoimmune disease affecting the central nervous system (CNS). It is characterized by degeneration of axons and axal demyelination. Prevalence of multiple sclerosis is 30 per 100 000 people in the world. In this article we aim to analyze and compare the selected measuring tools evaluating the quality of life in patients affected by MS. The studied measuring tools are: the Multiple Sclerosis Quality of Life Inventory (MSQLI), the Health-Related Quality of Life Questionnaire for Multiple Sclerosis (HRQOL-MS), the Multiple Sclerosis Quality of Life (MSQOL), the Functional Assessment of Multiple Sclerosis (FAMS), the Multiple Sclerosis Impact Scale (MSIS), the Multiple Sclerosis Functional Composite (MSFC), the Multiple Sclerosis International Quality of Life (MUSIQOL). Based on the selected studies we aim to compare the quality of life in MS patients. This article is directed towards the patients affected by MS and the specialist public. It aims to facilatate the navigation between the measuring tools evaluating the quality of life with multiple sclerosis.